康龙化成(03759)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03759 康龙化成

交易中 11-09 15:50:30

29.540

+0.400

+1.37%

最高30.580	最低29.160	成交量574.39万
今开29.440	昨收29.140	日振幅4.87%
总市值542.06亿	流通市值105.75亿	总股本18.35亿
成交额1.72亿	换手率1.60%	流通股本3.58亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03759","market":"HK","secType":"STK","nameCN":"康龙化成","latestPrice":29.54,"timestamp":1794210612355,"preClose":29.14,"halted":0,"volume":5743900,"delay":0,"changeRate":0.013726835964310178,"floatShares":358000000,"shares":1835000000,"eps":1.1039384187126065,"marketStatus":"交易中","change":0.4,"latestTime":"11-09 15:50:30","open":29.44,"high":30.58,"low":29.16,"amount":171930098,"amplitude":0.04873,"askPrice":29.54,"askSize":800,"bidPrice":29.52,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":1.1438555532310297,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1794211800000},"marketStatusCode":2,"adr":0,"listingDate":1574870400000,"exchange":"SEHK","adjPreClose":29.14,"dividendRate":0.007969,"openAndCloseTimeList":[[1794187800000,1794196800000],[1794200400000,1794211200000]],"volumeRatio":0.62611,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300759","market":"SZ","secType":"STK","nameCN":"康龙化成","latestPrice":44.5,"timestamp":1794207600000,"preClose":45.89,"halted":0,"volume":50459700,"delay":0,"premium":"-43.52"}},"requestUrl":"/m/hq/s/03759/wiki","defaultTab":"wiki","newsList":[{"id":"2682876428","title":"【券商聚焦】招银国际：中国创新药出海BD是核心动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2682876428","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682876428?lang=zh_cn&edition=full","pubTime":"2026-11-09 13:15","pubTimestamp":1794201346,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，2026年三季度，海外CXO和生命科学上游公司业绩延续逐季改善趋势，收入与调整后EPS中位数增速分别达+8.3%和+13.4%。生命科学上游改善最明显，CDMO受高基数影响增速放缓，临床前与临床CRO订单增长强劲，行业普遍上调全年指引。临床CRO订单维持增长，但可靠性受关注。生物药CDMO需求仍旺盛，但高基数致增速放缓。创新药融资三季度增速放缓，但2026全年预计实质性反弹，中国创新药出海BD是核心动力。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995526","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348827113.USD","LU0572944931.SGD","06821","LU0043850808.USD","LU2045819591.USD","IE00BFMHRM44.USD","LU0320764599.SGD","LU0455707207.USD","BK1141","LU0540923850.HKD","LU0128526141.USD","BK1610","LU0516422440.USD","01873","LU0181495838.USD","BK1191","HK0000320223.HKD","LU0051755006.USD","LU1688375341.USD","02359","KURE","HK0000306701.USD","06127","LU0417516902.SGD","LU0039217434.USD","LU0359202008.SGD","01548","LU0634319403.HKD","LU0856984785.SGD","KCE","LU0456846285.SGD","LU0348825331.USD","LU2039709279.SGD","LU0819121731.USD","BK1576","LU2399975544.HKD","01521","HK0000306685.HKD","LU0072913022.USD","LU0327786744.USD","LU0359201612.USD","03759","LU1242518931.SGD","LU0979878070.USD","02269","LU1046422090.SGD","LU0501845795.SGD","03347","LU0823426308.USD","LU0149721374.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129964814","title":"异动解读｜康龙化成盘中上涨3.29%，出资1000万美元参与境外股权投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=1129964814","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129964814?lang=zh_cn&edition=full","pubTime":"2026-11-09 09:51","pubTimestamp":1794189096,"startTime":"0","endTime":"0","summary":"11月9日，康龙化成盘中上涨3.29%，报30.1港元，成交额4108.78万港元。消息面上，公司公告全资子公司Pharmaron UK Limited拟作为有限合伙人，以自有或自筹资金认缴出资1000万美元参与投资HJ Double Helix Fund L.P.。该认购文件已于11月6日签署。此次投资旨在借助专业机构在生物医药行业的项目投资与研判能力，提升公司产业投资布局，与近期券商看好中国CDMO进入新发展阶段、公司订单增长与CRDMO兑现预期形成呼应。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康龙化成盘中上涨，出资千万布局境外基金","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682827161","title":"康龙化成（300759）11月6日主力资金净卖出3.05亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682827161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682827161?lang=zh_cn&edition=full","pubTime":"2026-11-09 09:47","pubTimestamp":1794188868,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月6日收盘，康龙化成报收于45.89元，下跌8.18%，换手率4.14%，成交量58.77万手，成交额27.62亿元。11月6日的资金流向数据方面，主力资金净流出3.05亿元，占总成交额11.05%，游资资金净流入7236.12万元，占总成交额2.62%，散户资金净流入2.33亿元，占总成交额8.44%。融券方面，融券卖出700.0股，融券偿还7200.0股，融券余量46.63万股，融券余额2140.08万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900002424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03759","BK1576","BK0216","BK1141","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682217468","title":"康龙化成出资1000万美元参与境外股权投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2682217468","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682217468?lang=zh_cn&edition=full","pubTime":"2026-11-09 07:35","pubTimestamp":1794180900,"startTime":"0","endTime":"0","summary":"模拟交易客户端康龙化成公布，为充分运用专业投资机构在生物医药行业内投资、研判的能力，公司的全资子公司 Pharmaron UK Limited拟作为有限合伙人以自有或自筹资金认缴出资 1，000 万美元参与投资 HJ Double Helix Fund L.P．。2026 年 11 月 6 日，康龙英国签署了基金认购文件，据此认购基金有限合伙权益，受基金《Amended and Restated Agreement of Exempted Limited Partnership of HJ Double Helix Fund L.P．》相关条款的约束并享有相应权利。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-11-09/doc-iniyauwh6637226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03759","BK0216","BK1576","BK1141","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681857706","title":"康龙化成(03759)出资1000万美元参与境外股权投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2681857706","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681857706?lang=zh_cn&edition=full","pubTime":"2026-11-06 18:59","pubTimestamp":1793962752,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成 公布，为充分运用专业投资机构在生物医药行业内投资、研判的能力，公司的全资子公司 Pharmaron UK Limited拟作为有限合伙人以自有或自筹资金认缴出资 1,000 万美元参与投资 HJ Double Helix Fund L.P.。2026 年 11 月 6 日，康龙英国签署了基金认购文件，据此认购基金有限合伙权益，受基金《Amended and Restated Agreement of Exempted Limited Partnership of HJ Double Helix Fund L.P.》相关条款的约束并享有相应权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1519855.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","03759","BK1576","BK0216","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147354939","title":"康龙化成：摩根大通减持，好仓比例降至16.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=1147354939","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147354939?lang=zh_cn&edition=full","pubTime":"2026-11-06 17:42","pubTimestamp":1793958125,"startTime":"0","endTime":"0","summary":"摩根大通于2026年11月2日以每股均价27.0559港元场外卖出康龙化成（03759）股份354.84万股，涉资约9600.55万港元；该笔为场外交易（代价性质：现金），未经联交所公开市场撮合，不属二级市场直接买卖。摩根大通此次减持前持有康龙化成好仓6467.68万，占比17.96%；减持后持股量为6112.84万，好仓比例降至16.98%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126579817","title":"康龙化成：摩根士丹利增持，好仓比例升至5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126579817","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126579817?lang=zh_cn&edition=full","pubTime":"2026-11-06 17:32","pubTimestamp":1793957522,"startTime":"0","endTime":"0","summary":"2026年11月3日，摩根士丹利通过增加其可行使再质押或处置权的股份权益，增持康龙化成（03759）H股93.21万股。该变化属于非公开市场的权益安排，并非透过联交所公开市场撮合成交，亦不属二级市场直接买卖正股。摩根士丹利此次增持前持有康龙化成好仓1755.51万，占比4.9%；增持后持股量为1848.72万，好仓比例升至5.13%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681183700","title":"大行评级｜小摩：中国CDMO进入新发展阶段，首予康龙化成及凯莱英H股“增持”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2681183700","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681183700?lang=zh_cn&edition=full","pubTime":"2026-11-06 15:23","pubTimestamp":1793949835,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0216","BK1191","BK1141","BK0132","LU1328615791.USD","BK1576","06821","300759","002821","03759","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163533847","title":"异动解读｜康龙化成盘中下跌4.61%，CXO板块回落叠加机构持仓变动扰动情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1163533847","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163533847?lang=zh_cn&edition=full","pubTime":"2026-11-06 09:40","pubTimestamp":1793929228,"startTime":"0","endTime":"0","summary":"11月6日，康龙化成盘中下跌4.61%，报29.06港元，成交额5294.87万港元。同板块中，药明生物下跌3.45%，金斯瑞生物科技下跌10.87%，药明康德下跌2.94%，英矽智能下跌6.35%，药明合联下跌2.84%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"康龙化成盘中下跌，CXO板块集体走弱","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681882108","title":"康龙化成（300759）11月5日主力资金净买入1.06亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681882108","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681882108?lang=zh_cn&edition=full","pubTime":"2026-11-06 09:04","pubTimestamp":1793927093,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月5日收盘，康龙化成报收于49.98元，上涨7.69%，换手率5.05%，成交量71.66万手，成交额34.89亿元。11月5日的资金流向数据方面，主力资金净流入1.06亿元，占总成交额3.05%，游资资金净流出1.09亿元，占总成交额3.13%，散户资金净流入304.09万元，占总成交额0.09%。融券方面，融券卖出1.85万股，融券偿还1000.0股，融券余量47.28万股，融券余额2363.3万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600009303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK1141","03759","BK0216","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102197183","title":"异动解读｜康龙化成盘中上涨3.74%，CXO板块回暖叠加三季报增长预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1102197183","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102197183?lang=zh_cn&edition=full","pubTime":"2026-11-05 09:53","pubTimestamp":1793843599,"startTime":"0","endTime":"0","summary":"11月5日，康龙化成盘中上涨3.74%，报31.18港元，成交额1.06亿港元。消息面上，市场仍在消化公司此前披露的三季报与机构最新观点。公司前三季度营收120.03亿元，同比增长19.01%；归母净利润12.47亿元，同比增长9.31%；其中第三季度收入同比增长20.94%，CDMO收入同比增长30%，新签订单同比增长超过30%。同时，开源证券近日维持买入评级，预计公司归母净利润未来三年分别为22.13亿元、29.34亿元和37.65亿元。叠加CXO板块整体回暖，带动股价继续走强。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"康龙化成盘中上涨，CXO回暖叠加业绩增长","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680608030","title":"康龙化成（300759）披露实际控制人部分质押股份延期购回公告，11月04日股价上涨12.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680608030","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680608030?lang=zh_cn&edition=full","pubTime":"2026-11-04 19:28","pubTimestamp":1793791719,"startTime":"0","endTime":"0","summary":"截至2026年11月4日收盘，康龙化成报收于46.41元，较前一交易日上涨12.67%，最新总市值为852.68亿元。该股当日开盘41.18元，最高46.41元，最低40.6元，成交额达25.27亿元，换手率为4.09%。近日，康龙化成披露《关于公司实际控制人部分质押股份延期购回的公告》。本次延期不影响公司实际控制权，不涉及平仓风险。截至公告日，实际控制人及其一致行动人合计质押股份49,774,000股，占其所持股份比例16.40%，占公司总股本比例2.71%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400035672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300759","03759","BK1141","BK1576","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680303130","title":"11月4日康龙化成涨12.67%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680303130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680303130?lang=zh_cn&edition=full","pubTime":"2026-11-04 17:48","pubTimestamp":1793785728,"startTime":"0","endTime":"0","summary":"证券之星消息，11月4日康龙化成涨12.67%，收盘报46.41元，换手率4.09%，成交量58.08万手，成交额25.27亿元。根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共234家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为132.77亿元，最新净值1.7941，较上一交易日下跌1.44%，近一年下跌8.61%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400033172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","03759","159760","BK1576","BK0216","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680031812","title":"康龙化成涨12.67%，开源证券六日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2680031812","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680031812?lang=zh_cn&edition=full","pubTime":"2026-11-04 17:48","pubTimestamp":1793785715,"startTime":"0","endTime":"0","summary":"今日康龙化成涨12.67%，收盘报46.41元。2026年10月29日，开源证券研究员余汝意发布了对康龙化成的研报《公司信息更新报告：订单持续高增，CDMO收入及盈利能力同步改善》，该研报对康龙化成给出“买入”评级。研报中预计2026-2028年公司归母净利润为22.13/29.34/37.65亿元，EPS为1.20/1.60/2.05元，当前股价对应PE为32.9/24.8/19.3倍，维持“买入”评级。康龙化成个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400033167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03759","161027","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175255249","title":"康龙化成：摩根大通减持，好仓比例降至17.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=1175255249","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175255249?lang=zh_cn&edition=full","pubTime":"2026-11-04 17:42","pubTimestamp":1793785339,"startTime":"0","endTime":"0","summary":"摩根大通于2026年10月30日以每股均价27.669港元场外卖出康龙化成（03759）股份109.90万股，涉资约3040.92万港元；该笔为场外交易（代价性质：现金），未经联交所公开市场撮合，不属二级市场直接买卖。摩根大通此次减持前持有康龙化成好仓6577.58万，占比18.27%；减持后持股量为6467.68万，好仓比例降至17.96%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680519700","title":"CXO板块逆市走强 百济神州（06160）涨5.14%、凯莱英（06821）涨4.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680519700","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680519700?lang=zh_cn&edition=full","pubTime":"2026-11-04 10:34","pubTimestamp":1793759693,"startTime":"0","endTime":"0","summary":"金吾财讯 | CXO板块逆市走强，百济神州 涨5.14%，凯莱英涨4.19%，药明康德涨3.92%，药明生物涨3.58%，科伦博泰生物涨2.89%，药明合联涨2.44%，和铂医药-B涨1.76%，康龙化成涨1.46%，和黄医药涨1.17%。湘财证券表示，CXO龙头药明康德三季报超预期、指引上修，印证CXO由周期修复转向CRDMO结构性重估。维持药品行业“买入”评级，建议关注创新化学制剂及创新药产业链上游CXO公司。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995187","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WX","LU0051755006.USD","02268","LU2476274720.SGD","CXO","LU1720050803.USD","LU2476274308.USD","ONC","02359","LU0516422440.USD","LU0828237510.HKD","02269","06160","688235","LU0128522744.USD","LU0501845795.SGD","03759","LU0456827905.SGD","LU0348766576.USD","BK1574","LU0823426480.USD","LU0455707207.USD","BK0132","SG9999002562.SGD","LU0043850808.USD","LU0359202008.SGD","LU0502904849.HKD","LU2045819591.USD","02142","KURE","LU0072913022.USD","LU0229945570.USD","LU0823426308.USD","LU0588546209.SGD","SG9999002463.SGD","06990","LU0327786744.USD","LU0320764243.SGD","LU3063872942.SGD","00013","BK1141","LU1831875114.USD","LU0463099449.HKD","002821","LU0516423091.SGD","LU0326950275.SGD","06821","LU1242518857.USD","LU0128526141.USD","LU1719994722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199111660","title":"异动解读｜康龙化成盘中上涨5%，CXO板块回暖叠加业绩增长预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1199111660","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199111660?lang=zh_cn&edition=full","pubTime":"2026-11-04 09:43","pubTimestamp":1793756615,"startTime":"0","endTime":"0","summary":"11月4日，康龙化成盘中上涨5%，报27.3港元，成交额1543.66万港元。消息面上，公司此前披露前三季度营收120.03亿元，同比增长19.01%，归母净利12.47亿元，同比增长9.31%；其中第三季度收入和经调整净利润分别同比增长21%和25%，CDMO收入同比增长30%。多家机构维持买入评级，目标价看至46.6港元。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"康龙化成盘中走强，CXO回暖叠加订单增长","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118381367","title":"康龙化成（03759）公告：实控人楼小强合计737.4万股质押续期至2027年","url":"https://stock-news.laohu8.com/highlight/detail?id=1118381367","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118381367?lang=zh_cn&edition=full","pubTime":"2026-11-03 19:15","pubTimestamp":1793704531,"startTime":"0","endTime":"0","summary":"2026年11月3日，康龙化成（北京）新药技术股份有限公司发布公告称，公司实际控制人之一楼小强将其已质押的部分股份办理延期购回，合计涉及股份7,374,000股，占其所持股份的12.18%，占公司总股本的0.40%。截至公告披露日，楼小强持有公司60,540,050股，持股比例为3.30%。其中28,974,000股处于质押状态，占其持股总数的47.86%，占公司总股本的1.58%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680945741","title":"摩根大通在康龙化成的H股好仓比例下降0.51%至18.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680945741","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680945741?lang=zh_cn&edition=full","pubTime":"2026-11-03 17:22","pubTimestamp":1793697720,"startTime":"0","endTime":"0","summary":"南财智讯11月3日电，香港交易所披露信息显示，JPMorganChase&Co.（摩根大通）在康龙化成的H股好仓（L）比例于10月28日从18.95%下降至18.44%。同时淡仓（S）比例从4.12%降至3.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611033920342935.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611033920342935.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["300759","03759","PGF","BK4582","BK0216","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157777324","title":"康龙化成更新10月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1157777324","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157777324?lang=zh_cn&edition=full","pubTime":"2026-11-03 16:36","pubTimestamp":1793694999,"startTime":"0","endTime":"0","summary":"康龙化成（北京）新药技术股份有限公司于2026年11月3日发布了10月股份变动月报。报告期截止至2026年10月31日，公司注册股本维持在人民币1,837,283,628元，涵盖A股与H股两类普通股。其中，H股已发行股份为358,111,057股，库存股份为1,866,830股；A股已发行股份为1,477,305,741股；合计总股本较上月末保持不变。本月内，公司确认其已符合相关上市规则的公众持股比例要求，股本结构整体保持稳定。本次月报由公司秘书麦宝文签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pharmaron.com","stockEarnings":[{"period":"1week","weight":0.0801},{"period":"1month","weight":-0.0939},{"period":"3month","weight":0.0604},{"period":"6month","weight":0.5237},{"period":"1year","weight":0.195},{"period":"ytd","weight":0.5043}],"compareEarnings":[{"period":"1week","weight":0.051},{"period":"1month","weight":0.0146},{"period":"3month","weight":-0.0462},{"period":"6month","weight":-0.0724},{"period":"1year","weight":-0.0757},{"period":"ytd","weight":-0.0448}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康龙化成（北京）新药技术股份有限公司是一家主要从事医药研发的中国公司。该公司运营五个分部。实验室服务分部主要包括实验室化学和生物科学服务，服务项目涵盖小分子化学药、寡核苷酸、多肽、抗体、抗体偶联药物和细胞与基因治疗产品等。化学和制剂工艺开发及生产服务分部包括原料药工艺开发及生产以及预制剂、制剂开发。临床研究服务分部包括国外临床研究服务和国内临床研究服务。大分子和细胞与基因治疗服务分部包括大分子药物发现及开发与生产服务和细胞与基因治疗实验室及基因治疗药物开发与生产服务。该公司还通过其他分部开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.020006},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.034007},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.039454},{"month":4,"riseRate":0.857143,"avgChangeRate":0.052246},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.006682},{"month":6,"riseRate":0.714286,"avgChangeRate":0.071007},{"month":7,"riseRate":0.714286,"avgChangeRate":0.108056},{"month":8,"riseRate":0.428571,"avgChangeRate":0.003953},{"month":9,"riseRate":0.714286,"avgChangeRate":0.134481},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.067263},{"month":11,"riseRate":0.428571,"avgChangeRate":0.042419},{"month":12,"riseRate":0.571429,"avgChangeRate":0.025859}],"exchange":"SEHK","name":"康龙化成","nameEN":"PHARMARON"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康龙化成(03759)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康龙化成(03759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康龙化成,03759,康龙化成股票,康龙化成股票老虎,康龙化成股票老虎国际,康龙化成行情,康龙化成股票行情,康龙化成股价,康龙化成股市,康龙化成股票价格,康龙化成股票交易,康龙化成股票购买,康龙化成股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康龙化成(03759)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康龙化成(03759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}